Literature DB >> 29885255

The association between liver cirrhosis and fracture risk: A systematic review and meta-analysis.

Jie Liang1, Wei-Dong Meng1, Jun-Ming Yang1, Sheng-Long Li1, Mi-Na Zhong2, Xuan-Xuan Hou1, Ran Wang1, Yu-Ying Long3, Liang-Xiao Bao1, Ming Bao1.   

Abstract

OBJECTIVE: Liver cirrhosis (LC) was associated with an increased risk of osteoporosis; however, the association between LC and fracture risk was inconclusive. Therefore, this systematic review and meta-analysis aims to explore the association between LC and fracture risk.
DESIGN: To identify related literature, a systematic search of PubMed, EMBASE, Web of science and the Cochrane Library from 1965 to July 2017 without language limitation was performed. The random-effects model described by DerSimonian and Laird was used to calculate pooled odds ratios (ORs) and 95% confidence intervals (CIs).
RESULTS: Eventually, 5 cohort and 3 case-control studies were identified, which included 321 035 subjects and 31 272 fracture cases. The pooled OR of the association between LC and any fracture risk, hip fracture, spine/trunk fracture and limb fracture was 1.94 (95% CI, 1.59-2.37), 2.11 (95% CI, 1.34-3.32), 2.00 (95% CI, 1.50-2.67) and 1.82 (95% CI, 1.65-2.01), respectively.
CONCLUSION: In conclusion, this study indicates that cirrhotic patients have an increased risk of fracture. Preventive measures should be instituted as early as possible.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  cirrhosis; fracture; meta-analysis; primary biliary cirrhosis

Mesh:

Year:  2018        PMID: 29885255     DOI: 10.1111/cen.13762

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  8 in total

1.  CORR Insights®: Hip Fractures in Patients With Liver Cirrhosis: Worsening Liver Function is Associated with Increased Mortality.

Authors:  Lisa K Cannada
Journal:  Clin Orthop Relat Res       Date:  2022-02-08       Impact factor: 4.755

2.  Portal vein thrombosis is associated with an increased risk of bone fractures.

Authors:  Simon Johannes Gairing; Peter Robert Galle; Jörn Markus Schattenberg; Karel Kostev; Christian Labenz
Journal:  PLoS One       Date:  2022-04-22       Impact factor: 3.752

3.  CT and MRI features of calvarium and skull base osteosarcoma (CSBO).

Authors:  Zhendong Luo; Weiguo Chen; Xinping Shen; Genggeng Qin; Jianxiang Yuan; Biying Hu; Jianxun Lyu; Derun Pan
Journal:  Br J Radiol       Date:  2019-11-28       Impact factor: 3.039

4.  Head and neck osteosarcoma: CT and MR imaging features.

Authors:  Zhendong Luo; Weiguo Chen; Xinping Shen; Genggeng Qin; Jianxiang Yuan; Biying Hu; Jianxun Lyu; Chanjuan Wen; Weimin Xu
Journal:  Dentomaxillofac Radiol       Date:  2019-10-30       Impact factor: 2.419

5.  Plasma pentosidine levels are associated with prevalent fractures in patients with chronic liver disease.

Authors:  Chisato Saeki; Mitsuru Saito; Tomoya Kanai; Masanori Nakano; Tsunekazu Oikawa; Yuichi Torisu; Masayuki Saruta; Akihito Tsubota
Journal:  PLoS One       Date:  2021-04-02       Impact factor: 3.240

6.  Chronic liver disease and cirrhosis increase morbidity in geriatric patients treated surgically for hip fractures: analysis of the US Nationwide Inpatient Sample.

Authors:  Feng-Jen Tseng; Guo-Hau Gou; Sheng-Hao Wang; Jia-Fwu Shyu; Ru-Yu Pan
Journal:  BMC Geriatr       Date:  2022-02-23       Impact factor: 3.921

7.  Increased rate of enteric bacteria as cause of periprosthetic joint infections in patients with liver cirrhosis.

Authors:  Uta S Koepf; Sebastian Scheidt; Gunnar T R Hischebeth; Christian P Strassburg; Dieter C Wirtz; Thomas M Randau; Philipp Lutz
Journal:  BMC Infect Dis       Date:  2022-04-19       Impact factor: 3.667

8.  Usefulness of the Trabecular Bone Score in Assessing the Risk of Vertebral Fractures in Patients with Cirrhosis.

Authors:  Yui Ogiso; Tatsunori Hanai; Kayoko Nishimura; Takao Miwa; Toshihide Maeda; Kenji Imai; Atsushi Suetsugu; Koji Takai; Masahito Shimizu
Journal:  J Clin Med       Date:  2022-03-12       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.